Is the Mattress sector outperforming NIFTY 500?
Mattress has underperformed NIFTY 500 by 9.6% over 52 weeks and 15.7% over 13 weeks. 1 of 1 covered companies beat NIFTY on Mansfield relative strength, while 1 of 1 beat the sector itself.
Mattress: Sheela Foam Ltd owns the largest revenue base AND the fastest current growth.
The Mattress companies below are the listed Indian Mattress universe this page tracks — the same constituent set people search for as the Nifty Mattress index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.
Mattress has underperformed NIFTY 500 by 9.6% over the last 52 weeks. Over 13 weeks the gap is a lead of 15.7%. 1 of 1 covered company currently beats NIFTY on Mansfield relative strength, so leadership inside the sector is broad. Sheela Foam Ltd is the strongest against the sector itself at +21.1%. Readings are as of 2026-07-19.
Equal-weight current-member sector proxy and NIFTY 500 are rebased to 100 over the latest 52 weeks.
Sector metric: 36.9 as of 2026-07-19 · CONSOLIDATION · falling.
The central tension: current leadership is concentrated, so durability matters more than rank.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Mattress has underperformed NIFTY 500 by 9.6% over 52 weeks and 15.7% over 13 weeks. 1 of 1 covered companies beat NIFTY on Mansfield relative strength, while 1 of 1 beat the sector itself. Sheela Foam Ltd leads with revenue of ₹3,820 crore, based on 2 of 2 comparable companies through Mar 2026.
Mattress has underperformed NIFTY 500 by 9.6% over 52 weeks and 15.7% over 13 weeks. 1 of 1 covered companies beat NIFTY on Mansfield relative strength, while 1 of 1 beat the sector itself.
Sheela Foam Ltd leads with revenue of ₹3,820 crore, based on 2 of 2 comparable companies through Mar 2026.
Sheela Foam Ltd has the fastest current revenue growth at 11.1%, across 1 of 2 comparable companies.
Sheela Foam Ltd ranks first at 76.7/100 with 94% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Wakefit Innovations Ltd reports the largest latest CAPEX at ₹8 crore, with 1 of 2 companies comparable.
Wakefit Innovations Ltd has the lowest comparable gross debt at ₹272 crore. Sheela Foam Ltd has the highest at ₹908 crore.
Sheela Foam Ltd has the lowest comparable Guarded PEG at 1.09, among 1 of 2 companies that pass the metric’s comparability rules.
The page compares up to 20 reported quarters per company for fundamentals, CAPEX, debt and valuation, ending Mar 2026. Missing observations remain blank rather than being estimated.
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is guarded: positive earnings, positive 5–60% three-year EPS growth, and a positive P/E are required.
76.7/100 · Favorable setup · 94% evidence
Exact sum: 31.1 + 12.6 + 13 + 20 = 76.7
Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
Revenue 11.1% · PAT 67% · OPM change 8 pp
95% evidence
ROCE 6.1% · debt/equity 0.28×
95% evidence
P/E 55.3× · PEG 1.09
85% evidence
RS sector 21.1% · RS bench 23.1% · 1Y 13%
100% evidence
54.3/100 · Thin evidence · provisional · 39% evidence
Exact sum: 23.1 + 11.2 + 10 + 10 = 54.3
Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
Revenue — · PAT — · OPM change 9 pp
41% evidence
ROCE 11.2% · debt/equity 0.24×
100% evidence
P/E 22.3× · PEG —
0% evidence
RS sector — · RS bench — · 1Y —
0% evidence
Sheela Foam Ltd has the highest Revenue among the 2 Mattress companies compared here, at ₹3,820 crore. Wakefit Innovations Ltd is next at ₹1,504 crore. The same company also holds the highest Revenue growth, at 11.1%. 2 of 2 companies report a comparable reading, the latest through Mar 2026. Its Revenue series carries 20 reported observations across the 20-quarter window.
What the numbers say: Sheela Foam Ltd is the scale leader at ₹3,820 crore, 154% ahead of Wakefit Innovations Ltd. Sheela Foam Ltd's growth is 11.1% from a ₹3,820 crore base, with 20 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: Sheela Foam Ltd is the scale benchmark; Sheela Foam Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Sheela Foam Ltd's growth falls below Sheela Foam Ltd's for two consecutive comparable reports while operating margin also compresses.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Sheela Foam Ltd SFL | ₹1.1K Cr | 24% | Mar 2026 |
| Wakefit Innovations Ltd WAKEFIT | ₹344 Cr | 14% | Mar 2026 |
Sheela Foam Ltd has the highest OPM among the 2 Mattress companies compared here, at 11%. Wakefit Innovations Ltd has the highest Margin change at +9 percentage points, so level and change sit with different companies. 2 of 2 companies report a comparable reading, the latest through Mar 2026. Its OPM series carries 20 reported observations across the 20-quarter window.
What the numbers say: Sheela Foam Ltd leads opm at 11%; Wakefit Innovations Ltd leads margin change at +9 percentage points.
Investor read: Sheela Foam Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| Sheela Foam Ltd SFL | 11% | +8.0 pp | Mar 2026 |
| Wakefit Innovations Ltd WAKEFIT | 11% | +9.0 pp | Mar 2026 |
Wakefit Innovations Ltd has the highest Net profit among the 2 Mattress companies compared here, at ₹188 crore. Sheela Foam Ltd is next at ₹162 crore. Sheela Foam Ltd has the highest Profit growth at 67%, so level and change sit with different companies. 2 of 2 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Wakefit Innovations Ltd leads with ₹188 crore of TTM profit, 16% above Sheela Foam Ltd. Sheela Foam Ltd shows 67% growth from a ₹162 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: Wakefit Innovations Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| Wakefit Innovations Ltd WAKEFIT | ₹122 Cr | — | Mar 2026 |
| Sheela Foam Ltd SFL | ₹92 Cr | 608% | Mar 2026 |
Wakefit Innovations Ltd has the highest CAPEX among the 2 Mattress companies compared here, at ₹8 crore. The same company also holds the highest CAPEX intensity, at 2.1%. 1 of 2 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Wakefit Innovations Ltd reports ₹8 crore of CAPEX; Wakefit Innovations Ltd has the highest covered intensity at 2.1%. Coverage is only 1 of 2 companies and 3 reported observations, so this is partial evidence—not a complete sector rank.
Investor read: Use the CAPEX rank as a diligence queue. Verify commissioning, utilization, cash conversion and post-investment ROCE before treating spend as value creation.
This conclusion weakens if: CAPEX rises without higher utilization, operating cash flow or incremental returns.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | CAPEX | CAPEX intensity | Reported |
|---|---|---|---|
| Wakefit Innovations Ltd WAKEFIT | ₹8 Cr | 2.1% | Mar 2026 |
Capacity base is net fixed assets plus capital work in progress, straight off the reported balance sheet. It is not cash spent, so it answers a narrower question than CAPEX — but it is reported for companies whose cash-flow CAPEX is not published, which is why it leads here. Missing years remain blank; annual values are never relabelled as quarters.
Wakefit Innovations Ltd has the lowest Gross debt among the 2 Mattress companies compared here, at ₹272 crore. Sheela Foam Ltd is next at ₹908 crore. The same company also holds the lowest Net debt, at ₹391 crore net cash. 2 of 2 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Wakefit Innovations Ltd has the clearest covered balance-sheet capacity with ₹391 crore net cash and gross debt of ₹272 crore. Absolute debt alone does not identify the strongest balance sheet because company scale differs; net debt and debt-to-equity carry more information.
Investor read: Prioritize net-cash capacity and leverage relative to operating scale, not the smallest absolute rupee debt.
This conclusion weakens if: Net debt rises faster than revenue and profit for two consecutive reported periods.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Gross debt | Net debt | Reported |
|---|---|---|---|
| Sheela Foam Ltd SFL | ₹908 Cr | ₹738 Cr | Mar 2026 |
| Wakefit Innovations Ltd WAKEFIT | ₹272 Cr | ₹-391 Cr | Mar 2026 |
Wakefit Innovations Ltd has the highest ROCE among the 2 Mattress companies compared here, at 11.2%. Sheela Foam Ltd is next at 6.1%. The same company also holds the highest ROCE change, at +9.3 percentage points. 2 of 2 companies report a comparable reading, the latest through Mar 2026. Its ROCE series carries 5 reported observations across the 20-quarter window.
What the numbers say: Wakefit Innovations Ltd leads ROCE at 11.2%, 5.1 percentage points above Sheela Foam Ltd. Wakefit Innovations Ltd has the strongest latest improvement at +9.3 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
Investor read: Wakefit Innovations Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Sheela Foam Ltd SFL | 6.6% | +4.7 pp | Mar 2026 |
| Wakefit Innovations Ltd WAKEFIT | 5.9% | +9.3 pp | Mar 2026 |
Sheela Foam Ltd has the lowest Guarded PEG among the 2 Mattress companies compared here, at 1.09×. Wakefit Innovations Ltd has the lowest P/E at 22.3×, so level and change sit with different companies. 1 of 2 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Sheela Foam Ltd has the lowest comparable Guarded PEG at 1.09×. Only 1 of 2 companies pass the guard, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Guarded PEG | P/E | Reported |
|---|---|---|---|
| Sheela Foam Ltd SFL | 1.1 | 62.3 | Mar 2026 |
| Wakefit Innovations Ltd WAKEFIT | — | 26.5 | Mar 2026 |
Sheela Foam Ltd has the lowest EV/EBITDA among the 2 Mattress companies compared here, at 16.5×. Wakefit Innovations Ltd is next at 62.6×. The same company also holds the lowest P/BV, at 2.56×. 2 of 2 companies report a comparable reading, the latest through Mar 2026. Its EV/EBITDA series carries 20 reported observations across the 20-quarter window.
What the numbers say: Sheela Foam Ltd leads both ev/ebitda at 16.5× and p/bv at 2.56×.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/bv signal.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | EV/EBITDA | P/BV | Reported |
|---|---|---|---|
| Wakefit Innovations Ltd WAKEFIT | 62.6 | 4.4 | Mar 2026 |
| Sheela Foam Ltd SFL | 16.5 | 1.7 | Mar 2026 |
Sheela Foam Ltd has the strongest one-year price move in Mattress at +13%. It also leads on Mansfield relative strength against NIFTY at +23.1%. 1 of 1 covered company is above zero on that measure. Every line covers 313 weekly closes through 2026-07-24.
Price is rebased to 100 inside the selected window. Pair ratio rebases each selected company against one chosen denominator.
This Mattress comparison names 5 specific ways its own evidence can mislead, all listed below. All 2 companies here report on comparable dates, so no rank carries a stale marker. 2 of the 8 ranked sections have fewer than three usable current readings. A high growth rate can still be a low-base artefact.
All 2 companies in the canonical Mattress membership are listed below, largest market value first — nothing is silently dropped, even where a company reports too little to rank. The charts above default to a selective view; this register is the complete set, with each company's own latest reporting date beside it.
| Company | Market value | Price | Priced to | Latest fundamentals | Source standing |
|---|---|---|---|---|---|
| Sheela Foam Ltd SFL | ₹8.3K Cr | ₹762 | 2026-07-24 | Mar 2026 | Cross-checked |
| Wakefit Innovations Ltd WAKEFIT | ₹4.3K Cr | ₹130 | 2026-07-24 | Mar 2026 | Cross-checked |
This comparison is built from the reported filings of 2 Mattress companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Mar 2026 and market data through 2026-07-24. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from. Every company's standing is listed in the register above.
These 19 answers restate the Mattress comparison above in question form. Every one is computed from the same 2 companies and the same reported filings as the rankings and charts, current through Mar 2026. Price and relative-strength answers run through 2026-07-24. Nothing here is estimated, and none of it is a recommendation.
The Nifty Mattress index tracks India's listed Mattress companies as a single basket. This page follows the same 2 companies and equal-weights them, so every company's weekly return counts once whatever it is worth, and the reading belongs to the Mattress sector rather than to its largest constituent. Figures are as of Mar 2026.
Ranked by this page's four-factor score, Sheela Foam Ltd places first among 2 listed Mattress companies, followed by Wakefit Innovations Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Mar 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
This comparison covers 2 listed Mattress companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Mar 2026.
Sheela Foam Ltd is the largest, with trailing-twelve-month revenue of ₹3,820 crore, ahead of Wakefit Innovations Ltd at ₹1,504 crore. That covers 2 of 2 companies with comparable reporting through Mar 2026.
Sheela Foam Ltd has the fastest revenue growth at 11.1% year on year, across 1 of 2 comparable companies. Fast growth off a small base is not the same as proven scale — check whether the rate holds across several quarters on the chart above before treating it as a trend.
Sheela Foam Ltd has the highest operating margin at 11%, from 2 of 2 comparable companies. Wakefit Innovations Ltd shows the biggest recent improvement, at +9 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Wakefit Innovations Ltd earns the most, at ₹188 crore of trailing-twelve-month net profit, from 2 of 2 comparable companies. Sheela Foam Ltd has the fastest profit growth at 67%, though growth off a small or recovering profit base overstates how much has actually changed.
Wakefit Innovations Ltd leads on return on capital employed at 11.2%, across 2 of 2 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
On guarded PEG — where a LOWER number is cheaper — Sheela Foam Ltd screens cheapest at 1.09×. Only 1 of 2 companies pass the comparability guard, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Wakefit Innovations Ltd carries the lowest comparable gross debt at ₹272 crore, from 2 of 2 companies. Absolute rupee debt alone does not settle it, because company scale differs — net debt and debt-to-equity in the chart above carry more information, and a very low-debt balance sheet can also mean under-investment.
Wakefit Innovations Ltd reports the largest capital spending at ₹8 crore, across 1 of 2 companies. Spending consumes cash before it earns anything, so treat the ranking as a diligence queue: check commissioning, utilisation and the return earned on the completed assets before reading spend as value creation.
Mattress has underperformed NIFTY 500 by 9.6% over the last 52 weeks and 15.7% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 1 of 1 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Sheela Foam Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Sheela Foam Ltd scores 76.7 out of 100 with 94% evidence confidence, from 31.1 points on growth and earnings, 12.6 on capital efficiency, 13 on valuation and 20 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
It compares 2 listed companies over up to 20 reported quarters of fundamentals and 10 fiscal years of capital allocation, ending Mar 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
The 2 Mattress companies on this page carry ₹12,618 crore of combined market value. Sheela Foam Ltd is the largest at ₹8,321 crore, about 66% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-07-29.
1 of the 1 covered Mattress companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 9.6% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-07-29.
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.